References
- KapoorKGWagnerMGWagnerALThe Sustained-Release Dexamethasone Implant: Expanding Indications in Vitreoretinal DiseaseSemin Ophthalmol Epub2014321
- ComynOLightmanSLHykinPGCorticosteroid intravitreal implants vs ranibizumab for the treatment of vitreoretinal diseaseCurr Opin Ophthalmol20132424825423518614
- CallananDGJaffeGJMartinDFPearsonPAComstockTLTreatment of posterior uveitis with a fluocinolone acetonide implant: three-year clinical trial resultsArch Ophthalmol20081261191120118779477
- KaneFEBurdanJCutinoAGreenKEIluvien: a new sustained delivery technology for posterior eye diseaseExpert Opin Drug Deliv200851039104618754752
- WilliamsGAHallerJAKuppermanBDDexamethasone posterior-segment drug delivery system in the treatment of macular edema resulting from uveitis or Irvine-Gass syndromeAm J Ophthalmol20091471048105419268890
- HallerJAKuppermanBDBlumenkranzMSRandomized controlled trial of intravitreous dexamethasone drug delivery system in patients with diabetic macular edemaArch Ophthalmol201012828929620212197
- HallerJABandelloFBelfortRJrOZURDEX GENEVA Study GroupRandomized, sham-controlled trial of dexamethasone intravitreal implant in patients with macular edema due to retinal vein occlusionOphthalmology20101171134114620417567
- US Food and Drug AdministrationOzurdex®: Highlights of Prescribing InformationSilver SpringUS Food and Drug Administration2014 Available from: http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/022315s010lbl.pdfAccessed January 17, 2015
- LowderCBelfortRJrLightmanSOzurdex HURON Study GroupDexamethasone intravitreal implant for noninfectious intermediate or posterior uveitisArch Ophthalmol2011129554555321220619
- Tomkins-NetzerOTaylorSRBarATreatment with repeat dexamethasone implants results in long-term disease control in eyes with noninfectious uveitisOphthalmology201412181649165424650556
- LatronicoMERiganteDCasoFBilateral dexamethasone intravitreal implant in a young patient with Vogt-Koyanagi-Harada disease and refractory uveitisClin Rheumatol Epub2014425
- SaatciAOSelverOBSeymenogluGYamanABilateral intravitreal dexamethasone implant for retinitis pigmentosa-related macular edemaCase Rep Ophthalmol201341535823616764
- SharmaAShethJMadhusudanRJSundaramoorthySKEffect of intravitreal dexamethasone implant on the contralateral eye: a case reportRetin Cases Brief Rep20137321721925391109
- KiernanDFMielerWFThe use of intraocular corticosteroidsExpert Opin Pharmacother200910152511252519761356
- DriotJYNovackGDRittenhouseKDMilazzoCPearsonPAOcular pharmacokinetics of fluocinolone acetonide after Retisert intravitreal implantation in rabbits over a 1-year periodJ Ocul Pharmacol Ther20042026927515279731
- GoldsteinDAGodfreyDGHallAIntraocular pressure in patients with uveitis treated with fluocinolone acetonide implantsArch Ophthalmol20071251478148517923537
- HallerJABandelloFBelfortRJrDexamethasone intravitreal implant in patients with macular edema related to branch or central retinal vein occlusion twelve-month study resultsOphthalmology2011118122453246021764136
- KhuranaRNAppaSNMcCannelCADexamethasone implant anterior chamber migration: risk factors, complications, and management strategiesOphthalmology20141211677123890421
- BakriSJRiscoMEdwardsAOPulidoJSBilateral simultaneous intravitreal injections in the office settingAm J Ophthalmol20091481666919403114
- MonteroJARuiz-MorenoJMIntravitreal inserts of steroids to treat diabetic macular edemaCurr Diabetes Rev200951263219199895
- CaoJHMulvahillMZhangLJoondephBCDaceyMSDexamethasone intravitreal implant in the treatment of persistent uveitic macular edema in the absence of active inflammationOphthalmology20141211871187624907061